576 related articles for article (PubMed ID: 24043739)
1. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Donker M; Litière S; Werutsky G; Julien JP; Fentiman IS; Agresti R; Rouanet P; de Lara CT; Bartelink H; Duez N; Rutgers EJ; Bijker N
J Clin Oncol; 2013 Nov; 31(32):4054-9. PubMed ID: 24043739
[TBL] [Abstract][Full Text] [Related]
2. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age.
Miles RC; Gullerud RE; Lohse CM; Jakub JW; Degnim AC; Boughey JC
Ann Surg Oncol; 2012 Apr; 19(4):1153-9. PubMed ID: 21989658
[TBL] [Abstract][Full Text] [Related]
4. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
5. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.
Wärnberg F; Garmo H; Emdin S; Hedberg V; Adwall L; Sandelin K; Ringberg A; Karlsson P; Arnesson LG; Anderson H; Jirström K; Holmberg L
J Clin Oncol; 2014 Nov; 32(32):3613-8. PubMed ID: 25311220
[TBL] [Abstract][Full Text] [Related]
6. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.
Rakovitch E; Pignol JP; Hanna W; Narod S; Spayne J; Nofech-Mozes S; Chartier C; Paszat L
J Clin Oncol; 2007 Dec; 25(35):5591-6. PubMed ID: 17984188
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; Espié M; Cuvier C
Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
[TBL] [Abstract][Full Text] [Related]
8. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
Galper S; Blood E; Gelman R; Abner A; Recht A; Kohli A; Wong JS; Smith D; Bellon J; Connolly J; Schnitt S; Winer E; Silver B; Harris JR
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):348-57. PubMed ID: 15667952
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
Jiveliouk I; Corn B; Inbar M; Merimsky O
Oncology; 2009; 76(1):30-5. PubMed ID: 19033713
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
11. Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.
Hamilton SN; Nichol A; Wai E; Gondara L; Velásquez García HA; Speers C; Diocee R; Truong P
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):381-388. PubMed ID: 30253237
[TBL] [Abstract][Full Text] [Related]
12. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy.
White J; Levine A; Gustafson G; Wimbish K; Ingold J; Pettinga J; Matter R; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):791-7. PubMed ID: 7860390
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
Lagios MD; Silverstein MJ
Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503
[TBL] [Abstract][Full Text] [Related]
14. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194.
Motwani SB; Goyal S; Moran MS; Chhabra A; Haffty BG
Cancer; 2011 Mar; 117(6):1156-62. PubMed ID: 21381008
[TBL] [Abstract][Full Text] [Related]
16. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
[TBL] [Abstract][Full Text] [Related]
17. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
[TBL] [Abstract][Full Text] [Related]
18. Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk.
Tunon-de-Lara C; Lemanski C; Cohen-Solal-Le-Nir C; de Lafontan B; Charra-Brunaud C; Gonzague-Casabianca L; Mignotte H; Fondrinier E; Giard S; Quetin P; Auvray H; Cutuli B
Eur J Surg Oncol; 2010 Dec; 36(12):1165-71. PubMed ID: 20889280
[TBL] [Abstract][Full Text] [Related]
19. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results.
Kestin LL; Goldstein NS; Martinez AA; Rebner M; Balasubramaniam M; Frazier RC; Register JT; Pettinga J; Vicini FA
Ann Surg; 2000 Feb; 231(2):235-45. PubMed ID: 10674616
[TBL] [Abstract][Full Text] [Related]
20. Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.
Rakovitch E; Sutradhar R; Lalani N; Nofech-Mozes S; Gu S; Goldberg M; Hanna W; Fong C; Paszat L
Breast Cancer Res Treat; 2019 Nov; 178(1):169-176. PubMed ID: 31325071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
